Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Protocol of the Can Nebulised Heparin Reduce Time to Extubation in SARS-CoV-2 (CHARTER) Study

Barry Dixon, Roger J Smith, Antonio Artigas, John Laffey, Bairbre McNicholas, Eric Schmidt, View ORCID ProfileQuentin Nunes, View ORCID ProfileMark Skidmore, Marcelo Andrade de Lima, John L Moran, Frank VanHaren, Gordon Doig, Angajendra Ghosh, Simone Said, Sachin Gupta, John D Santamaria
doi: https://doi.org/10.1101/2020.04.28.20082552
Barry Dixon
1Department of Critical Care Medicine, St Vincent’s Hospital (Melbourne), Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: barry.dixon{at}svha.org.au
Roger J Smith
1Department of Critical Care Medicine, St Vincent’s Hospital (Melbourne), Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antonio Artigas
2Critical Care Center, Corporació Sanitaria Universitaria Parc Tauli, CIBER Enfermedades Respiratorias, Autonomous University of Barcelona, Sabadell, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Laffey
3Centre for Medical Devices, National University of Ireland Galway; Department of Intensive Care Medicine, University Hospital, Galway, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bairbre McNicholas
3Centre for Medical Devices, National University of Ireland Galway; Department of Intensive Care Medicine, University Hospital, Galway, Ireland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Schmidt
4Department of Critical Care Medicine, Denver Medical Centre, University of Colorado, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Quentin Nunes
5Department of Surgery, University of Liverpool, Aintree University Hospital, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Quentin Nunes
Mark Skidmore
6Molecular & Structural Biosciences, Keele University, Staffordshire, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mark Skidmore
Marcelo Andrade de Lima
6Molecular & Structural Biosciences, Keele University, Staffordshire, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L Moran
7Department of Intensive Care Medicine, The Queen Elizabeth Hospital, South Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank VanHaren
8Department of Intensive Care Medicine, Canberra Hospital, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gordon Doig
9Northern Clinical School Intensive Care Research Unit, University of Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angajendra Ghosh
10Intensive Care Unit, The Northern Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Simone Said
10Intensive Care Unit, The Northern Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sachin Gupta
11Intensive Care Unit, Frankston Hospital, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John D Santamaria
1Department of Critical Care Medicine, St Vincent’s Hospital (Melbourne), Victoria, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Introduction COVID-19 is associated with the development of ARDS displaying the typical features of diffuse alveolar damage with extensive pulmonary coagulation activation resulting in fibrin deposition in the microvasculature and formation of hyaline membranes in the air sacs. The anti-coagulant actions of nebulised heparin limit fibrin deposition and progression of lung injury. Serendipitously, unfractionated heparin also inactivates the SARS-CoV-2 virus and prevents its entry into mammalian cells. Nebulisation of heparin may therefore limit both fibrin-mediated lung injury and inhibit pulmonary infection by SARS-CoV-2. For these reasons we have initiated a multi-centre international trial of nebulised heparin in patients with COVID-19.

Methods and intervention Mechanically ventilated patients with confirmed or strongly suspected SARS-CoV-2 infection, hypoxaemia and an acute pulmonary opacity in at least one lung quadrant on chest X-ray, will be randomised to nebulised heparin 25,000 Units every 6 hours or standard care for up to 10 days while mechanically ventilated. The primary outcome is the time to separation from invasive ventilation to day 28, where non-survivors to day 28 are treated as though not separated from invasive ventilation.

Ethics and dissemination The study protocol has been submitted to the human research and ethics committee of St Vincent’s Hospital, Melbourne, Australia. Submission is pending in other jurisdictions. Results of this study will be published in scientific journals and presented at scientific meetings.

Trial Registration ACTRN: 12620000517976

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ACTRN: 12620000517976

Funding Statement

No external funding was received

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data can be obtained by contacting the chief investigator

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted May 12, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Protocol of the Can Nebulised Heparin Reduce Time to Extubation in SARS-CoV-2 (CHARTER) Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Protocol of the Can Nebulised Heparin Reduce Time to Extubation in SARS-CoV-2 (CHARTER) Study
Barry Dixon, Roger J Smith, Antonio Artigas, John Laffey, Bairbre McNicholas, Eric Schmidt, Quentin Nunes, Mark Skidmore, Marcelo Andrade de Lima, John L Moran, Frank VanHaren, Gordon Doig, Angajendra Ghosh, Simone Said, Sachin Gupta, John D Santamaria
medRxiv 2020.04.28.20082552; doi: https://doi.org/10.1101/2020.04.28.20082552
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Protocol of the Can Nebulised Heparin Reduce Time to Extubation in SARS-CoV-2 (CHARTER) Study
Barry Dixon, Roger J Smith, Antonio Artigas, John Laffey, Bairbre McNicholas, Eric Schmidt, Quentin Nunes, Mark Skidmore, Marcelo Andrade de Lima, John L Moran, Frank VanHaren, Gordon Doig, Angajendra Ghosh, Simone Said, Sachin Gupta, John D Santamaria
medRxiv 2020.04.28.20082552; doi: https://doi.org/10.1101/2020.04.28.20082552

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Intensive Care and Critical Care Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3294)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13376)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14628)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1705)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)